A study of intravenous vinorelbine and oral capecitabine in patients with advanced breast cancer
Phase 2
Completed
- Conditions
- Breast CancerCancer - Breast
- Registration Number
- ACTRN12606000370505
- Lead Sponsor
- Dr. Alison Davis, Dr Stephen Ackland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Advanced/ metastatic breast cancer; maximum of 1 prior chemotherapy for metastatic cancer; at lteat `1 measurable lesion by RECIST; > 18 years; KPS > 80%; adequate organ function
Exclusion Criteria
Life expectance <12 weeks; significant comorbidities; peripheral neuropathy > grade1; other invasive cancers; unable to swallow pills whole
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method